Product Details
Product Name:
TOK-8801 |
CAS No.:
105963-46-0 |
Purity:
99.25% |
Supply Ability:
10g |
Release date:
2024/11/20 |
Product Introduction
Bioactivity
Name | TOK-8801 |
Description | TOK-8801 is a synthetic dihydroimidazole thiazole carboxamide with immunomodulatory activity that eliminates the stimulatory effects of antibody production by removing T cells.128-63-63-5 |
In vitro | TOK-8801 enhanced the anti-sheep red blood cells (SRBC) plaque forming cells (PFC) response and mitogen-induced proliferative responses in murine splenocytes and thymocytes in vitro at concentrations of 10(-7)-10(-5) M, while LMS augmented these responses at 10(-4) M[1]. |
In vivo | TOK-8801 (0.5 mg/kg, p.o.) suppressed the production of anti-SRBC PFC in normal mice, but restored the inhibition of antibody production in restraint stress mice[1]. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Keywords | TOK-8801 | TOK 8801 | TOK8801 |
Related Compound Libraries | Bioactive Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:59870-65-4
$73.00 / 1mg
-
CAS:363600-92-4
$47.00 / 1mg
-
CAS:603288-22-8
$41.00 / 1mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$293.00/1mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-11-20 |